Ambry Genetics drives innovation in diagnostics by launching cutting-edge genetic tests and technologies. Its broad collaborations, novel research projects, and networks for data sharing ...

On February 19, Tempus AI, Inc. (NASDAQ:TEM) secured $300 million in additional debt financing from Ares Management’s Credit ...

The deal also brings integration and execution risks. Ambry, a 25-year-old genetics testing firm, is expected to generate over $300 million in revenue this year, with growth boosted by market ...